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A Systematic Review and Meta- Analysis of Green-Light Laser Vaporization for Superficial Bladder 
Cancer
Zhi Xu1,2,*, Guifen Gan1,*, Guojun Chen2, Guanlin Wu3,4
Purpose: The related research of green-light laser vaporization in the treatment of non-muscle invasive bladder 
cancer (NMIBC) is limited. This study focused on analyzing the effectiveness and safety of it from the perspective 
of an extensive literature review.
Methods: A comprehensive search of CNKI, WanFang, VIP, PubMed, Embase, and CENTRAL databases for 
photoselective vaporization of bladder tumor and transurethral resection of bladder tumor treatment of non-mus-
cle invasive bladder cancer (NMIBC). The search included studies from January 1996 to December 2019. Two 
reviewers independently screened literature, extracted data, assessed the risk of bias of included studies. RevMan 
5.3 software was used for Meta-analysis. 
Results: A total of 18 RCTs involving 1648 patients met the predefined criteria. Meta-analysis data demonstrated 
that the PVBT group exhibited a significant advantage over the TURBT group in intraoperative obturator nerve 
reflex (RR = 0.09, 95% CI [0.04, 0.18], P < 0.001) and bladder perforation (RR = 0.14, 95% CI [0.07, 0.28], P < 
0.001) and postoperative 1-year recurrence (RR = 0.52, 95% CI [0.40, 0.67], P< 0.001). The PVBT procedure has 
advantages over TURBT in the amount of surgical bleeding (MD = −17.27, 95% CI [−24.73, −9.81], P < 0.001) 
and the length of hospital stay (MD = −2.80, 95% CI [−3.82, −1.87], P < 0.001), bladder irrigation time (MD = 
−0.95, 95% CI [−1.49, −0.42], P< 0.001), and catheter indwelling time (MD = −2.60, 95% CI [−3.30, −1.90], P <
0.001). There was no difference between the two types of surgery in the incidence of postoperative urethral stric-
ture (RR = 0.53, 95% CI [0.15, 1.83], P = 0.32) and the length of surgery (MD = −2.46, 95% CI [−5.37, 0.46], P
= 0.10).
Conclusion: Our systematic review and meta-analysis suggests that PVBT is better than TURBT as an alternative 
treatment for patients with NMIBC in safe aspect. However, whether it is equally effective in terms of oncological 
control remains to be elucidated, and additional high quality RCTs are needed to confirm our findings.
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INTRODUCTION
By incidence, bladder cancer ranks seventh among systemic malignancies and first among urinary tu-
mors (1). With an emphasis on painless gross hematuria 
and the extensive use of ultrasound, CT (computerized 
tomography), cystoscopy, and urine, the early diagno-
sis of bladder cancer has been significantly improved(1). 
Under the new lymph node, tumor, metastasis (NTM) 
staging method, bladder cancer can be divided into 
non-muscle-invasive bladder cancer (stages Tis, Ta, 
T1) and muscle-invasive invasive bladder cancer (stag-
es T2 or higher). Approximately 70–80% of patients 
with bladder cancer present with non-muscle-invasive 
bladder cancer NMIBC (formerly known as superfi-
cial bladder cancer)(2). NMIBC has a high recurrence 
rate, and the recurrence rate after the first operation can 
exceed 50%. The treatment and prognosis of bladder 
cancer are closely related to the stage classification and 
postoperative treatment. The treatment of NMIBC is 
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mainly based on partial surgery and complete resection 
of the tumor plus postoperative intravesical instillation 
of chemotherapy drugs to prevent recurrence. At pres-
ent, the surgical treatment recommended by the guide-
lines domestically and abroad is transurethral resection 
of the bladder tumor (TURBT)(3, 4) and is the preferred 
treatment of NMIBC. TURBT is a high-frequency elec-
tric transurethral resection of tumor tissue which re-
quires no incision on the surface. It can be repeated, and 
it involves less trauma and is subject to a quicker recov-
ery than other surgical methods. However, TURBT is 
prone to intraoperative obturator nerve reflex, bladder 
perforation, and other problems such as dilutive hypon-
atremia and transurethral resection syndrome, and the 
recurrence rate is high(5). TURBT can also cause mi-
crovascular and lymphatic vessels to rupture, and the 
cut tumor tissue can become disseminated within the 
bladder, increasing the probability of tumor lymphatic 
metastasis and distant implantation in vivo(6).Since the 
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end of the last century, laser technology has been used 
throughout urology. This technology has been widely 
used in clinical practice due to its safety, minimal in-
vasiveness, and a positive therapeutic effect(7). In 2002, 
Laserscope pioneered the 80W green laser surgery sys-
tem and applied it to benign prostatic hyperplasia. Since 
then, green laser has emerged as a new technology for 
the treatment of urinary diseases(8). The green laser 
(KTP laser) is easily absorbed by oxidized hemoglobin, 
but it is not easily absorbed by water, so it is called "se-
lective light." As a result, it can better utilize its energy 
in human tissues to generate thermal energy, thus caus-
ing a vaporization effect. The green laser surgery sys-
tem is mainly limited to the shallow surface of the tissue 
surface with a depth of approximately 0.8 mm. At the 
same time the tissue is vaporized, a solidification zone 
of 1–2 mm is formed on the surface of the tissue, which 
facilitates a strong hemostasis. Another advantage of 
the green laser is that it does not produce an electric 
field effect. In theory, it can avoid the stimulation of 
the obturator nerve by the current as well as induce 
nerve reflex, which reduces the incidence of bladder 
perforation(9,10). We performed a systematic review of 
RCTs using meta-analysis to determine whether there 
are any differences between the intraoperative and post-
operative outcomes, in addition to oncologic outcomes, 
between these two approaches, in order to determine 
whether transurethral laser treatment techniques can be 
appropriate alternatives to TURBT.
METHODS
The search terms and search strategies were developed 
according to the Cochrane Handbook for Systematic 
Reviews of Interventions(11). The search languages were 
Chinese and English, and the CNKI, VIP, WangFang, 
CBM, PubMed, EMBase, and the Cochrane Library da-
tabases were utilized for this study. The databases were 
searched from January 1996 until December 2019. The 
corresponding search terms were “laser,” “KTP la-
ser,” “electric resection,” “bladder tumor,” and “green 
laser” and “urinary bladder neoplasms.” Some of the 
search terms had no subject word correspondence, such 
as “NMIBC,” so the search was supplemented by free 
words and synonyms, such as "green laser", "greenlight 
laser", "PVBT", "KTP", "urinary bladder neoplasms", 
"bladder neoplasm", "bladder tumor", "urinary blad-
der cancer" and "bladder cancer". Additionally, search 
terms were linked together via using the appropriate 
logical operators, synonyms were connected with “or”, 
“and” was applied to search terms with different mean-
Green-light laser vaporization in superficial bladder cancer-Xu et al.
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Table 1. List of basic characteristics of the incorporated literature
Inclusive Number of cases P Average age (years)  Male patient Female patient Base-line  Follow-up
study  VBT/TURBT PVBT/TURBT PVBT/TURBT PVBT/TURBT comparability outcome
Xu et al. 2015 [29] 99/94 63.06/62.82 80/76 19/18 Yes 
Li et al. 2017 [12] 34/30 49.6/50.7 20/16 14/14 Yes
Zhang et al. 2016 [13] 43/43 56.41/52.29 28/26 15/17 Yes 
Wang et al. 2016 [14] 60/60 57.23/57.65 33/32 27/28 Yes 
Liu 2015 [15] 43/43 62.3/60.5 31/29 12//14 Yes
Han et al. 2015 [16] 59/59 65.29/65.76 32/31 27/28 Yes 
Liu et al. 2015 [17] 31/30 53.20/51.93 23/21 8//9 Yes 
Shen et al. 2015 [18] 120/120 54.2* 108* 132* Yes 
Wen et al. 2014 [19] 30/30 56/57 23/22 7//8 Yes 
Ge et al. 2011 [20] 24/24 46.5* 27* 21* Yes 
Luo et al. 2011 [21] 28/28 60.5* 43* 13* Yes 
Cao and Cao 2011 [22] 46/47 56/58 25/26 21/21 Yes 
Li et al. 2010 [23] 35/35 65/62 26/25 9//10 Yes
Wang et al. 2009 [24] 44/51 59.71/58.6  29/42 15//9 Yes 
Huo et al. 2008 [25] 35/32 56/52 26/26 9//6 Yes 
Deng et al. 2008 [26] 42/42 62/58 23/24 19/18 Yes 
Liu and Li 2007 [27] 20/20 65.5/62.5 15/15 5/5 Yes 
Jiang et al. 2006 [28] 42/25 65* 57* 10* Yes 
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ings.
For a study to be considered eligible, it had to meet the 
following criteria: (1) It was a randomized controlled 
clinical trial; (2) The study subjects were patients di-
agnosed with NMIBC; (3) The experimental group 
was treated with transurethral bladder tumor green la-
ser selective vaporization (PVBT group) and the con-
trol group was treated with transurethral resection of 
bladder tumor (TURBT group).(4) Research indicators 
must include at least four or more of the following in-
dicators, such as the amount of surgical bleeding and 
the length of hospital stay, bladder irrigation time, and 
catheter indwelling time, urethral stricture, obturator 
nerve reflex and bladder perforation and postoperative 
recurrence rate. Studies were excluded if they met the 
following criteria: (1) Non-randomized controlled tri-
als; (2) Too small of a total sample size (<40 cases ren-
dered the complication index difficult to observe); (3) 
The original research data could not be obtained even if 
you contact the original author by email or other means. 
The study was a repeat publication, or the original data 
record was incomplete; (4) Presence of upper urinary 
tract tumors and other operations at the same time; (5) 
Non-green lasers such as helium neon, holmium laser, 
red laser, 2 μm laser, and semiconductor laser, among 
others; (6) There were too few outcome indicators. 
The search process was completed by two independ-
ent researchers (Xu, and Wu). If there was any disa-
greement in the search process, Professor Chen would 
provide professional advice and a re-search may have 
Table 2 List of quality evaluation of the incorporated literature
Inclusion study  Generation of  Randomized Blind Withdrawal and  Score
   random sequences  hiding  method loss of follow-up 
Yansheng Xu, 2015 Computer generated  Sealed envelope Single Described and 7
   randomly     blind pro-cessed
Yijian Li, 2017  Random test with-out  No clear  Not Not  2
   describing method    described described
Jianchao Zhang, 2016 Computer generated randomly computer control Not Not  4
        described described
Zhancheng Wang, 2016 Random test with-out  No clear  Not Not  2
   describing method    described described
Kun Liu, 2015  Random number table method No clear  Not Not  3
        described described
Qianhe Han, 2015 Random number table method No clear  Not Not  2
        described described
Zhifeng Liu, 2015 Random test with-out  No clear  Not Not  2
   describing method    described described
Yizhen Shen, 2015 Random number table method No clear  Not Not  3
        described described
Yongan Wen, 2014 Random test with-out  No clear  Not Not  2
   describing method    described described
Guangcheng Ge, 2011 Random test with-out  No clear  Single Not  3
   describing method    blind described
Bin Luo, 2011  Random test with-out  No clear  Not Not  2
   describing method    described described
Shiyi Cao, 2011  Random test with-out  No clear  Single Not  3
   describing method    blind described
Jian Li, 2010  Random test with-out  No clear  Not Not  2
   describing method    described described
Li Wang, 2009  Random test with-out  No clear  Not Describe the 3
   describing method    described loss of follow-up
Lizhi Huo, 2008  Random test with-out  No clear  Not Not  2
   describing method    described described
Gang Deng, 2008  Random test with-out  No clear  Single Not  3
   describing method    blind described
Weijun Liu, 2007  Random test with-out  No clear  Not Not  2
   describing method    described described
Shaobo Jiang, 2006 Random test with-out  No clear  Not Not  2
   describing method    described described
Note: 1-3 points are considered general quality and 4-7 points are considered high quality.
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been completed. In the end, Professor Chen will check 
whether the retrieval process and the retrieval results 
are correct. The quality of the included research litera-
ture was evaluated based on the improved Jadad scale. 
The evaluation of literature quality is mainly based on 
the following aspects: random sequence generation, 
random hiding, blind method implementation, exit and 
loss of follow-up.
Study parameters included duration of surgery, intraop-
erative blood loss, length of hospital stay, duration of 
catheterization, bladder irrigation, obturator nerve re-
flex, bladder perforation, tumor recurrence, and urethral 
stricture. Meta-analysis was performed using RevMan 
5.3 statistical software (London, United Kingdom). The 
count data took Relative Risk (RR) as the effect index, 
and the measurement data used Mean Difference (MD) 
as the effect index. Each effect amount provided a point 
estimate and a 95% Confidence Interval (CI). First, het-
erogeneity analysis was carried out for each study. The 
χ2 test was also carried out (the test level was set to α 
= 0.1), and the heterogeneity was judged by I2. If the 
studies were homogenous (I2< 50%), a meta-analysis 
was performed using a fixed effect model. If the studies 
were heterogeneous (I2> 50%), a random effects model 
was used for meta-analysis. For obvious heterogenei-
ty, sensitivity analysis and other methods were used for 
processing. The test level for the meta-analysis was α 
= 0.05.
Sensitivity analysis was not performed on the research 
indicators with good homogeneity in the included stud-
ies. For the indicators with greater heterogeneity, two 
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Figure 1. Studies identified, included and excluded.
Figure 2. Meta-analysis comparing PVBT and TURBT in NMIBC 
with respect to the issues following the procedure.(A) Obturator 
nerve reflex. (B) Bladder perforation. (C) Time required for sur-
gery (minutes). (D) Intraoperative blood loss (cc). PVBT: pho-
toselective vaporization of bladder tumor; TURBT: transurethral 
resection of bladder tumor; NMBIC: non-muscle invasive bladder 
cancer.
Green-light laser vaporization in superficial bladder cancer-Xu et al.
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methods, single-removal method and selection model 
analysis method, were used for sensitivity analysis. If 
there is no difference in the results of two methods, the 
meta-analysis is reliable. If there are differences in the 
results of the sensitivity analysis, it is suggested that 
there are factors that affect the effectiveness of the in-
tervention, and caution must be exercised when inter-
preting the results and drawing conclusions.
For research indicators with more than 10 included arti-
cles, funnel charts were used to determine whether there 
is publication bias. If the points are evenly distributed 
on both sides of the midline in the funnel chart, it indi-
cates that there is no publication bias. On the contrary, 
there is publication bias. If there is too little relevant 
literature for an index, no funnel chart was made.
RESULTS
Through the preliminary search, 560 literatures were 
obtained, and 18 literatures were obtained by reading 
the title, abstract and full text of the articles and refer-
ring to the inclusion and exclusion criteria(12-29). The 
total number of cases was 1,648, including 835 in the 
PVBT group and 813 in the TURBT group. The specif-
ic search process is shown in Figure 1.
According to the original data obtained from the lit-
erature, baseline data, such as surgical grouping, age, 
gender, tumor staging/grading, tumor number, and po-
sition, were plotted and compared, and all the studies 
were consistent with baseline data (Table 1). Tumor 
staging in different articles at different time period was 
based on different AJCC staging versions which are 
5th, 6th, and 7th, respectively. Nevertheless, the stag-
ing of superficial bladder cancer was consistent in these 
tumor staging criteria. Therefore, the AJCC staging 
doesn’t affect our results.
The quality of 18 included articles was evaluated ac-
cording to the modified Jadad scale. Among them, there 
were 2 high quality documents and 16 general quality 
documents (Table 2).
There were 14 publications(11,13-17,19,20,22-24, 26-28) which 
met the criteria of obturator nerve reflex inclusion. The 
heterogeneity analysis results (I2 = 0, P = 0.72) indi-
cated good homogeneity among various studies. Me-
ta-analysis of them revealed that the obturator nerve 
reflex in the operation was lower in the PVBT group 
than in the TURBT group and the result was statistical 
significant (RR = 0.09, 95% CI [0.04, 0.18], Z = 6.91, 
P < 0.001, Figure 2A). Funnel plot showed no publica-
tion bias (Figure 4A).
Quantitative analysis of 14 researches(15-18, 20-29) uncov-
ered the probability of bladder perforation in the PVBT 
group was lower than in the TURBT group (RR = 0.14, 
95% CI [0.07, 0.28], Z = 5.35, P < 0.001, Figure 2B) in 
a statistically relevant manner. These articles were in 
good homogeneity (I2 = 0, P = 1.00) and no publication 
bias was found (Figure 4B).
Quantitative analysis of the basic data of 13 arti-
cles(12-19,21,23,25,27) (MD = −2.46, 95% CI [−5.37, 0.46], Z 
= 1.65, P = 0.10) indicated that the difference was not 
statistically significant, and there was no difference in 
the time required for surgery between the PVBT group 
and TURBT group (Figure 2C). There was a strong 
heterogeneity among included articles for surgical time 
(I2 = 91%, P < 0.001) and publication bias was found 
(Figure 4C). Sensitivity analysis revealed that the re-
sults of removal single study and change effect model 
are inconsistent, which indicated that the results and 
conclusions of the index is of poor reliability.
Quantitative analysis of 8 studies(14,16,18,19, 21,23, 25,27) (MD 
= −17.27, 95% CI [−24.73, −9.81], Z = 4.54, P < 0.001) 
showed that the amount of surgical bleeding of PVBT 
group was significantly less than TURBT group (Fig-
ure 2D). Since there was a strong heterogeneity (I2 = 
99%, P < 0.001), sensitivity analysis was performed 
and no difference between results of removal single 
study and change effect model was found, suggesting 
that the analysis of intraoperative blood loss was reli-
able.
Of the 18 articles included in the study, only three 
specifically described the urethral stricture after sur-
Figure 3. Meta-analysis comparing PVBT and TURBT in NMIBC 
with respect to the issues post-procedure. (A) Urethral stricture. 
(B) Tumor recurrence. (C) Length of hospital stay (days). (D) 
Duration of catheterization (days). (E) Bladder irrigation (days). 
PVBT: photoselective vaporization of bladder tumor; TURBT: 
transurethral resection of bladder tumor; NMBIC: non-muscle in-
vasive bladder cancer.
Green-light laser vaporization in superficial bladder cancer-Xu et al.
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gery (18,20,28). Quantitative analysis of the data regard-
ing urethral stricture post-surgery in these three papers 
was performed (18, 20, 28) (RR = 0.53, 95% CI [0.15, 
1.83], Z = 1.00, P = 0.32, Figure 3A). Hence, there was 
no difference in the incidence of postoperative urethral 
stricture between the PVBT group and the TURBT 
group.
Quantitative analysis of the basic data of 17 RCT stud-
ies(12-15,17-30) that met the criteria (RR = 0.52, 95% CI 
[0.40, 0.67], Z = 5.11, P < 0.001) demonstrated sta-
tistical significance. The rate of recurrence of bladder 
tumors after PVBT was lower than that of the TURBT 
group (Figure 3B). The included studies represented a 
good homogeneity (I2 = 0, P = 0.66) and no publication 
bias (Figure 4D).
Quantitative analysis of the length of hospital stay of 
the 10 works(12-14,16,18,19,21,23,25,30) (MD = −2.80, 95% CI 
[−3.82, −1.87], Z = 5.37, P < 0.001) illustrated that the 
length of hospital stay of PVBT group was significantly 
less than TURBT group (Figure 3C). The heterogenei-
ty analysis results (I2 = 98%, P < 0.001) indicated there 
was strong heterogeneity existed. However, sensitivi-
ty analysis suggested the meta-analysis was reliable as 
there was no difference between results of removal sin-
gle study and change effect model. Funnel plot showed 
that the distribution of each point was diffuse and un-
even, so publication bias was considered (Figure 4E).
Quantitative analysis of the underlying data of 12 stud-
ies (12-19, 21, 23, 25, 30) (MD = −2.60, 95% CI [−3.30, −1.90], 
Z = 7.29, P < 0.001) indicated that the duration of cath-
eter indwelling of PVBT group was significantly less 
than TURBT group (Figure 3D). There was a strong 
heterogeneity depending on the heterogeneity analysis 
results (I2 = 98%, P < 0.001). The sensitivity analysis 
suggested there was no difference between results of 
removal single study and change effect model. A con-
sidered publication bias was shown in funnel plot (Fig-
ure 4F).
Postoperative bladder irrigation time data from the re-
maining 7 studies(12,14,17-19,21,25) were analyzed (MD = 
−0.95, 95% CI [−1.49, −0.42], Z = 3.48, P < 0.001), 
and the difference between the PVBT group and the 
TURBT group in the postoperative bladder irrigation 
time was statistically significant. That is, postoperative 
bladder irrigation time was significantly shorter in the 
PVBT group than in the TURBT group (Figure 3E). 
Heterogeneity was considered according to the heter-
ogeneity analysis results (I2 = 99%, P < 0.001). After 
sensitivity analysis, no difference between results of re-
moval single study and change effect model was shown, 
so the analysis was still reliable.
Through analysis, it was found that obturator nerve re-
flex, bladder perforation, urethral stricture, and tumor 
recurrence all showed good homogeneity. However, the 
amount of surgical bleeding, the duration of operation, 
length of hospital stay, the duration of catheter indwell-
ing, postoperative bladder irrigation time showed great-
er heterogeneity. The inconsistency of measurement 
tools, measurement units and measurement accuracy 
should be regarded as the source of heterogeneity.
Sensitivity analysis of the operation time were incon-
sistent, so the reliability of its related results and con-
clusions should be doubted. The amount of surgical 
bleeding, length of hospital stay, catheter indwelling 
time and bladder irrigation time all showed high heter-
ogeneity. But after sensitivity analysis, the results were 
still statistically significant, indicating that the results 
were reliable.
DISCUSSION 
Although societal and living standards have improved, 
the incidence of bladder cancer has increased, trending 
toward a younger age of diagnosis(1). Bladder cancer 
ranks third among global male cancers, with NMIBC 
accounting for 70% of cases (1). TURBT is the preferred 
surgical method for the treatment of NMIBC. However, 
with the continuous improvement of medical technol-
ogy, TURBT has come to be criticized for its various 
drawbacks(30). TURBT uses a high-frequency current 
to cut tumor tissue, and it is easy for thermal penetrat-
ing injuries to take place during the cutting process. It 
can also damage surrounding tissues and form eschar 
and scar tissue(30). Due to its electric field effect, it is 
apt to obturator nerve reflex, especially bladder wall 
tumors, thereby increasing clinical complications that 
include bladder perforation and adhesion formation(30). 
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Figure 4. Published bias analysis, funnel plot. (A) Obturator nerve reflection. (B) Bladder perforation. (C) The duration of operation 
(days). (D) The rate of recurrence of bladder tumors. (E) The length of hospital stay (days). (F) The duration of catheter indwelling (days).
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The rate of recurrence following TURBT is also high(1). 
In addition, in TURBT, the tumor tissue is repeatedly 
cut into pieces, which violates the principle of surgical 
tumor-free, that is, in order to prevent the spread of the 
tumor, the tumor should be removed as a whole, rather 
than from many individual tissues.
Green laser vaporization is already widely used in the 
treatment of bladder tumors, mainly in NMIBC. It is 
also used in muscle invasive bladder cancer(32). PVBT 
has obvious advantages over TURBT with regards to 
surgical complications including obturator nerve re-
flex, bladder perforation, and surgical bleeding. This 
is because the green laser does not produce an electric 
field effect, so it does not induce nerve reflection. At 
the same time, the tissue penetration is shallow, the in-
cidence of bladder perforation is small, and its selective 
absorption causes almost no bleeding during intraoper-
ative bleeding. Long-term follow-up studies have also 
demonstrated it to be superior to traditional resection 
in terms of postoperative recurrence rate(30). The green 
laser directly vaporizes the tumor tissue, reducing the 
probability that the tumor cells will be scattered in the 
bladder and cause distal implantation. The green laser 
vaporizes tissue at the same time to form a vaporiza-
tion zone on the surface of the tissue, which effectively 
blocks the microvessels and lymphatic vessels and re-
duces the possibility of cancer cells entering the lumen 
(33). However, laser vaporization also has its shortcom-
ings, that is, it cannot leave enough tissue samples for 
pathological diagnosis, and it is difficult to intuitively 
judge the depth of tumor invasion during surgery.
This article includes a total of 18 studies(12-29) that have 
been published thus far, with a combined sample size 
of 1,648 patients. Meta-analysis showed PVBT has 
obvious advantages over TURBT in the treatment of 
obturator nerve reflex and bladder perforation (the het-
erogeneity test was I2< 50%, P < 0.05).This is basical-
ly consistent with the current view, and the safety of 
PVBT has been verified repeatedly(29,31).
Regarding the amount of surgical bleeding, hospitaliza-
tion time, the duration of bladder irrigation and cathe-
ter indwelling, this meta-analysis showed that PVBT is 
superior to TURBT. Because of the big heterogeneity 
sensitivity analysis was carried out and the sensitivity 
analysis suggests that the conclusions of the four indi-
cators are reliable, and the safety of PVBT is verified. 
Heterogeneous sources are often considered inconsist-
ent with the familiarity of the green laser surgery sys-
tem and the inconsistent measurement methods.
In the incidence of postoperative urethral stricture and 
duration of the operation, the meta-analysis showed that 
there was no difference between the two surgical meth-
ods (P > 0.05), and the sensitivity analysis suggested 
that the results are stable and the conclusion is reliable. 
Overall, the efficiency and safety of PVBT has once 
again been verified(29). Based upon these findings, we 
surmise that PVBT is worth promoting as a standard 
procedure for the treatment of NMIBC.
Limitations of this study are as follows. 1) Although 
the incorporated literature is described as a randomized 
controlled clinical trial, most of the research literature 
does not specifically describe the methods of random 
sequence generation or concealing randomization. The 
implementation of blinding, withdrawal and follow-up 
were not described, leading to the possibility of selec-
tion bias, implementation bias, and measurement bias. 
2) In some of these studies, the ending indicators are 
not comprehensive. 3) Heterogeneity was found among 
some of the reports. Most of the included studies didn’t 
underscore whether they applied monopolar or bipolar 
TURBT. Not all the agents performing the experiments 
had the same degree of familiarity with the green laser 
surgery system. The measurement tools were also not 
the same. 4) The bladder intravesical adjuvant treat-
ment differed in several studies, the drugs and the intra-
vesical adjuvant treatment time were different. And the 
duration of postoperative follow-up time was different. 
Finally, these factors may affect the outcome indicators, 
which in turn affect the reliability of the conclusions(34), 
especially regarding to the recurrence rate of tumor. 
Hence, although the recurrence rate of tumor showed 
that PVBT was better than TURBT in the analysis of 
forest map, the analysis of recurrence rate was biased 
and the conclusion was not reliable.
CONCLUSIONS
Based on the data included in our meta-analysis, PVBT 
is safer than TURBT for patients with NMIBC, but 
whether it is equally effective in terms of oncological 
control remains to be elucidated. However, additional 
randomized controlled trials with longer follow-up pe-
riods and larger sample sizes should be performed to 
verify our findings.
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